Skip to main content
Log in

Keshan disease and mitochondrial cardiomyopathy

  • Published:
Science in China Series C: Life Sciences Aims and scope Submit manuscript

Abstract

Keshan disease (KD) is a potentially fatal form of cardiomyopathy (disease of the heart muscle) endemic in certain areas of China. From 1984 to 1986, a national comprehensive scientific investigation on KD in Chuxiong region of Yunnan Province in the southwest China was conducted. The investigation team was composed of epidemiologists, clinic doctors, pathologists, biochemists, biophysicists and specialists in ecological environment. Results of pathological, biochemical and biophysical as well as clinical studies showed: an obvious increase of enlarged and swollen mitochondria with distended crista membranes in myocardium from patients with KD; significant reductions in the activity of oxidative phosphorylation (succinate dehydrogenase, cytochrome oxidase, succinate oxidase, H+-ATPase) of affected mitochondria; decrease in CoQ, cardiolipin, Se and GSHPx activity, while obvious increase in the Ca2+ content. So, it was suggested that mitochondria are the predominant target of the pathogenic factors of KD. Before Chuxiong KD survey only a few cases of mitochondrial cardiomyopathy were studied. During the multidisciplinary scientific investigation on KD in Chuxiong a large amount of samples from KD cases and the positive controls were examined. On the basis of the results obtained it was suggested that KD might be classified as a “Mitochondrial Cardiomyopathy” endemic in China. This is one of the achievements in the three years’ survey in Chuxiong and is valuable not only to the deeper understanding of pathogenic mechanism of KD but also to the study of mitochondrial cardiomyopathy in general.

Keshan disease is not a genetic disease, but is closely related to the malnutrition (especially microelement Se deficiency). KD occurs along a low Se belt, and Se supplementation has been effective in prevention of such disease. The incidence of KD has sharply decreased along with the steady raise of living standard and realization of preventive measures. At present, patients of KD are very sparse. In recent years the research on the non-KD mitochondrial cardiomyopathy has progressed rapidly. Given the advances in this aspect a minireview is written to evaluate the classification of KD as a kind of mitochondrial cardiomyopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Luft R, Ikkw D, Palmieri G, et al. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J Clin Invest, 1962, 41: 1776–1804

    PubMed  CAS  Google Scholar 

  2. Chinnery P F. Mitochondrial disorders overrview in Genereviews, 2003. www.genetests.org

  3. Zeviani M, Spinazzola A, Carelli V. Nuclear genes in mitochondrial disorders. Curr Opin Genet Dev, 2003, 13: 262–270

    Article  PubMed  CAS  Google Scholar 

  4. Lane N. Powerhouse of disease. Nature, 2006, 440: 600–602

    Article  PubMed  CAS  Google Scholar 

  5. Schapira A H V. Mitochondrial disease. the Lancet, 2006, 368: 70–82

    Article  CAS  Google Scholar 

  6. Gottlieb E, Tomlinson I P M. Mitochondrial tumor suppressors: a genetic and biochemical update. Nature Rev Cancer, 2005, 5: 857–866

    Article  CAS  Google Scholar 

  7. Anderson S, Bankier A T, Barrel B G, et al. Sequence and organization of the human mitochondrial genome. Nature, 1981, 290: 457–465

    Article  PubMed  CAS  Google Scholar 

  8. Holt I J, Harding A E, Hughes J A M. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988, 331: 717–719

    Article  PubMed  CAS  Google Scholar 

  9. Wallace D C, Singh G, Lott M T. Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science 1988, 242: 1427–1430

    Article  PubMed  CAS  Google Scholar 

  10. DiMauro S. Mitochondrial medicine. Biochim Biophys Acta (BBA) Bioenergetics, 2004, 1659(2–3): 107–114

    Article  CAS  Google Scholar 

  11. Servidei S. Mitochondrial encephalomyopathies: gene mutation. Neuromuscal Disord, 2004, 14: 107–116

    Article  Google Scholar 

  12. Niu C L, Hou L C, Li S X, Preliminary analysis of the morbidity fluctuation of Keshan disease and its relative factors in Chuxiong Prefecture. In: Yu W H, Wang F, eds. Proceedings of Comprehensive Scientific Investigation on KD in Chuxiong Region (in Chinese). Beijing: Peoples Health Press, 1988. 16–20

    Google Scholar 

  13. Li X Z. Preliminary examination of myocardium from patients with Keshan disease by electron microscopy. Scientia Sinica (Sci China) (in Chinese). 1974, (3): 415–417

  14. Yang D S. Defects of respiratory enzymes in myocardium of patients with Keshan disease. Endemic Disease Comm (in Chinese), 1982, 3: 1–5

    Google Scholar 

  15. Chuxiong Keshan Disease Pathological Team. The progress of the study on pathology during the scientific survey for KD in Chuxiong region. In: Yu W H, Wang F, eds. Proceedings of Comprehensive Scientific Investigation on KD in Chuxiong Region (in Chinese). Beijing: People’s Health Press, 1988. 138–141

    Google Scholar 

  16. Li F S, Yang D S. Progress of study on pathogenic mechanism of Keshan disease. In: Yu W H, Wang F, eds. Proceedings of Comprehensive Scientific Investigation on KD in Chuxiong Region (in Chinese). Beijing: People’s Health Press, 1988. 178–183

    Google Scholar 

  17. Yang F Y, Lin Z H, Li S G, et al. Keshan disease — an endemic Mitochondrial Cardiomyopathy. In: Yu W H, Wang F, eds. Proceedings of Comprehensive Scientific Investigation on KD in Chuxiong Region (in Chinese). Beijing: People’s Health Press, 1988. 184–192

    Google Scholar 

  18. Dai G H, Bai X Q, Yang D S. The changes of oxidative phosphorylation and respiratory enzymes in mitochondria of heart muscle from patients with KD. In: Yu W H, Wang F, eds. Proceedings of Comprehensive Scientific Investigation on KD in Chuxiong Region (in Chinese). Beijing: People’s Health Press, 1988, 193–197

    Google Scholar 

  19. Deng X Q, Li F Y, Xiao DY. Curative effect of CoQ10 adding digoxin on 15 cases of unstable latent Keshan disease. In: Yu W H, Wang F, eds. Proceedings of Comprehensive Scientific Investigation on KD in Chuxiong Region (in Chinese). Beijing: People’s Health Press, 1988. 130–131

    Google Scholar 

  20. Yang F Y, Lin Z H, Li S G, et al. Keshan disease — an endemic Mitochondrial Cardiomyopathy in China. J Trace Elem Electrolytes Health Dis, 1988, 2: 157–163

    PubMed  CAS  Google Scholar 

  21. Grantzow R, Hubner G. Mitochondrial Cardiomypathy with a high degree of heart muscle hypertrophy. Monatsschr Kinderheilkd, 1982, 130(12): 909–910

    PubMed  CAS  Google Scholar 

  22. Bogousslavsky J, Perentes E, Deruaz J P, et al. Mitochondrial myopathy and cardiomyopathy with neurodegenerative features and multiple brain infarcts. J Neurol Sci, 1982, 55(3): 351–357

    Article  PubMed  CAS  Google Scholar 

  23. Marin-Garcia J, Goldenthal M J. Cardiomyopathy and abnormal mitochondrial function. Cardiovasc Res, 1994, 28: 456–463

    Article  PubMed  CAS  Google Scholar 

  24. Marin-Garcia J, Goldenthal M J. Mitochondrial cardiomyopathy: Molecular and biochemical analysis. Pediatr Cardial, 1997, 18: 251–260

    Article  CAS  Google Scholar 

  25. Bindoff L. Mitochondria and heart. Eur Heart J, 2003, 24(3): 221–224

    Article  PubMed  CAS  Google Scholar 

  26. Chen X S. Relation of selenium deficiency to the occurrence of Keshan disease. In: Spallholz J E, Martin J L, Ganther H E, eds. Selenium in Biology and Medicine. Westport: AVI Publishing Co, 1981. 171–174

    Google Scholar 

  27. Keshan Disease Research Group of the Chinese Academy of Medical Sciences. Observation on effect of sodium selenite in prevention of Keshan disease. Chin Med J, 1979, 92: 471–476

    Google Scholar 

  28. Lab of Keshan Disease, Xi’an Medical College. The preventive effect by Na2SeO3 on the acute Keshan disease, Natl Med J China (in Chinese), 1979, 59(8): 457–459

    Google Scholar 

  29. Tan J A. Ecological environment of Keshan disease in Chuxiong region. In: Yu W H, Wang F, eds. Proceedings of Comprehensive Scientific Investigation on KD in Chuxiong Region (in Chinese). Beijing: People’s Health Press, 1988. 48–85

    Google Scholar 

  30. Yang F Y, Wo W H. Role of Se in stabilization of human erythrocyte membrane skeleton. Biochem Inter, 1987, 15: 475–482

    CAS  Google Scholar 

  31. Yang F Y, Yang M Z. Reaction of Se with SH groups in spectrin is involved in the stabilization of erythrocyte membrane skeleton. Biochem Inter, 1989, 18: 1085–1088

    CAS  Google Scholar 

  32. Yang F Y, Lin Z H, Xing J R, et al. Se deficiency is a necessary but not sufficient factor required for pathogenesis of Keshan Disease. J Clin Biochem Nutr, 1994, 16: 101–110

    Google Scholar 

  33. Ren L Q, Li X J, Li Q S, et al. Coxsakievirus B3 infection and its mutation in Keshan disease. World J Gastroenterol, 2004, 10(22): 3299–3302

    PubMed  CAS  Google Scholar 

  34. Li Y, Peng T, Yang Y, et al. High prevalence of enteroviral genomic sequences in myocardium from cases of endemic cardiomyopathy (Keshan disease) in China. Heart, 2000, 83: 696–701

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

In memory of 20th Anniversary of the accomplishment of Comprehensive Scientific Survey (1984–1986) of Keshan Disease in Chuxiong Region.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, F. Keshan disease and mitochondrial cardiomyopathy. SCI CHINA SER C 49, 513–518 (2006). https://doi.org/10.1007/s11427-006-2041-y

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11427-006-2041-y

Keywords

Navigation